BioLargo Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4.12	3.88	3.55	3.54	1.85	0.96
Cash & Short-Term Investments	4.12	3.88	3.55	3.54	1.85	0.96
Cash Growth	60.76%	9.44%	0.25%	91.19%	92.41%	34.36%
Receivables	0.73	0.62	3.17	2.61	1.06	0.51
Inventory	0.29	0.31	0.33	0.15	0.12	0.24
Prepaid Expenses	0.3	0.31	0.09	0.06	0.12	0.09
Total Current Assets	5.45	5.11	7.14	6.36	3.15	1.8
Property, Plant & Equipment	2.93	3.01	3.19	1.75	1.15	0.51
Long-Term Investments	-	-	0.01	0.02	0.03	0.05
Other Long-Term Assets	0.11	0.19	0.18	0.07	0.52	0.66
Total Assets	8.57	8.31	10.51	8.21	4.86	3.02
Accounts Payable	2.59	1.65	1.07	1.35	0.9	0.5
Accrued Expenses	-	0.22	0.15	0.3	0.28	0.29
Current Portion of Long-Term Debt	1.51	1.48	0.55	0.3	0.1	0.31
Current Portion of Leases	0.33	0.31	0.19	0.11	0.1	0.1
Current Unearned Revenue	0.32	0.28	-	0.3	0.02	0.09
Other Current Liabilities	0.19	1.13	0.68	0.36	0.18	0.08
Total Current Liabilities	4.93	5.06	2.65	2.71	1.58	1.37
Long-Term Debt	2.78	0.6	0.53	0.29	0.5	0.37
Long-Term Leases	1.04	1.12	1.28	1	0.77	0.35
Total Liabilities	8.75	6.79	4.46	4	2.85	2.09
Common Stock	0.21	0.21	0.2	0.2	0.19	0.17
Additional Paid-In Capital	165.35	165.32	158.33	154.02	148.44	143.72
Retained Earnings	-163.57	-161.28	-149.5	-147.1	-143.59	-139.12
Comprehensive Income & Other	-0.21	-0.21	-0.18	-0.28	-0.15	-0.12
Total Common Equity	1.79	4.04	8.85	6.84	4.88	4.65
Minority Interest	-1.97	-2.52	-2.8	-2.64	-2.87	-3.72
Shareholders' Equity	-0.19	1.53	6.06	4.2	2.01	0.93
Total Liabilities & Equity	8.57	8.31	10.51	8.21	4.86	3.02
Total Debt	5.66	3.51	2.55	1.7	1.47	1.13
Net Cash (Debt)	-1.54	0.37	0.99	1.84	0.38	-0.17
Net Cash Growth	-	-62.78%	-46.01%	380.68%	-	-
Net Cash Per Share	-0.00	0.00	0.00	0.01	0.00	-0.00
Filing Date Shares Outstanding	320.88	319.75	301.3	295.55	283.19	262.72
Total Common Shares Outstanding	319.7	317.38	301.27	292.95	278.46	255.89
Working Capital	0.51	0.05	4.49	3.65	1.58	0.43
Book Value Per Share	0.01	0.01	0.03	0.02	0.02	0.02
Tangible Book Value	1.79	4.04	8.85	6.84	4.88	4.65
Tangible Book Value Per Share	0.01	0.01	0.03	0.02	0.02	0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.